(Q47896635)

6 February 2018

title

Malaria vaccine trials in a wormy world. (English)

1 reference

6 February 2018

0 references

1 reference

Nacher M

1

1 reference

6 February 2018

publication date

1 December 2001

1 reference

6 February 2018

published in

Trends in Parasitology

1 reference

6 February 2018

volume

17

1 reference

6 February 2018

issue

12

1 reference

6 February 2018

page(s)

563-565

1 reference

6 February 2018

Severe falciparum malaria. World Health Organization, Communicable Diseases Cluster

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Immunization of man against sporozite-induced falciparum malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Immunity to non-cerebral severe malaria is acquired after one or two infections

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Malaria from Africa blows hot and cold

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

The immunology of malaria infection

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Immune dysregulation in Ethiopian immigrants in Israel: relevance to helminth infections?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Clinical trials of Plasmodium falciparum erythrocytic stage vaccines.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Immunological concepts of vaccine adjuvant activity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

The potential for recruiting immune responses toward type 1 or type 2 T cell help.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Impairment of tetanus toxoid-specific Th1-like immune responses in humans infected with Schistosoma mansoni.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Human infection with Ascaris lumbricoides is associated with suppression of the interleukin-2 response to recombinant cholera toxin B subunit following vaccination with the live oral cholera vaccine CVD 103-HgR.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Specific treatment of hepatosplenic schistosomiasis can increase T-lymphocyte reactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Chronic immune activation associated with intestinal helminth infections results in impaired signal transduction and anergy

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Evaluation of SPf66 malaria vaccine during a 22-month follow-up field trial in the Pacific coast of Colombia.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Efficacy trial of malaria vaccine SPf66 in Gambian infants

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Clustering of Ascaris lumbricoides and Trichuris trichiura infections within households

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Assessment of different sources of variation in the antibody responses to specific malaria antigens in children in Papua New Guinea

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

The complexity of protective immunity against liver-stage malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Common west African HLA antigens are associated with protection from severe malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Good worms or bad worms: do worm infections affect the epidemiological patterns of other diseases?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Ascaris lumbricoides infection is associated with protection from cerebral malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Socio-economic and environmental protective/risk factors for severe malaria in Thailand.

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Helminth infections are associated with protection from cerebral malaria and increased nitrogen derivatives concentrations in Thailand

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

The biological suppression of malaria: an ecological and nutritional interrelationship of a host and two parasites

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Contemporaneous and successive mixed Plasmodium falciparum and Plasmodium vivax infections are associated with Ascaris lumbricoides: an immunomodulating effect?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Parotid enlargement, forehead edema, and suppression of malaria as nutritional consequences of ascariasis

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Reduction in libido and fertility of male rats by administration of the nitric oxide (NO) synthase inhibitor N-nitro-L-arginine methyl ester

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Nitric oxide mediates sexual behavior in female rats

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Effects of age and parasitemia on nitric oxide production/leukocyte nitric oxide synthase type 2 expression in asymptomatic, malaria-exposed children

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

Are there pros as well as cons to being parasitized?

1 reference

https://api.crossref.org/works/10.1016%2FS1471-4922%2801%2902117-1

7 January 2021

10.1016/S1471-4922(01)02117-1

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

11756019

1 reference

6 February 2018